SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

por Cheng, Samuel MS, Mok, Chris Ka Pun, Chan, Karl CK, Ng, Susanna S, Lam, Bosco HS, Luk, Leo LH, Ko, Fanny W, Chen, Chunke, Yiu, Karen, Li, John KC, Chan, Ken KP, Tsang, Leo CH, Poon, Leo LM, Hui, David SC, Peiris, Malik
Publicado 2022

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

por Cheng, Samuel SM, Mok, Chris KP, Li, John KC, Ng, Susanna S, Lam, Bosco HS, Jeevan, Trushar, Kandeil, Ahmed, Pekosz, Andrew, Chan, Karl CK, Tsang, Leo CH, Ko, Fanny W, Chen, Chunke, Yiu, Karen, Luk, Leo LH, Chan, Ken KP, Webby, Richard J, Poon, Leo LM, Hui, David SC, Peiris, Malik
Publicado 2022

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020

por Perera, Ranawaka APM, Mok, Chris KP, Tsang, Owen TY, Lv, Huibin, Ko, Ronald LW, Wu, Nicholas C, Yuan, Meng, Leung, Wai Shing, Chan, Jacky MC, Chik, Thomas SH, Choi, Chris YC, Leung, Kathy, Chan, Kin Ho, Chan, Karl CK, Li, Ka-Chi, Wu, Joseph T, Wilson, Ian A, Monto, Arnold S, Poon, Leo LM, Peiris, Malik
Publicado 2020